{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T18:54:08Z","timestamp":1757616848385,"version":"3.44.0"},"reference-count":29,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,7,10]],"date-time":"2025-07-10T00:00:00Z","timestamp":1752105600000},"content-version":"vor","delay-in-days":39,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Nefrolog\u00eda (English Edition)"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1016\/j.nefroe.2025.501332","type":"journal-article","created":{"date-parts":[[2025,8,7]],"date-time":"2025-08-07T15:17:47Z","timestamp":1754579867000},"page":"501332","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Pharmacological nephrotoxicity profile in a comprehensive cancer center: What changed in two decades and predictors for the need for haemodialysis and mortality"],"prefix":"10.1016","volume":"45","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1166-7420","authenticated-orcid":false,"given":"Andr\u00e9","family":"Ferreira","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marina","family":"Reis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Teresa","family":"Chuva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2786-3688","authenticated-orcid":false,"given":"Hugo","family":"Ferreira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4240-8082","authenticated-orcid":false,"given":"In\u00eas","family":"Coelho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana","family":"Paiva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0408-7057","authenticated-orcid":false,"given":"Jos\u00e9 Maximino","family":"Costa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.nefroe.2025.501332_bib0150","doi-asserted-by":"crossref","first-page":"347","DOI":"10.2215\/CJN.03530412","article-title":"Incidence rate, clinical correlates, and outcomes of AKI in patients admitted to a comprehensive cancer center","volume":"8","author":"Salahudeen","year":"2013","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.nefroe.2025.501332_bib0155","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.ejim.2011.05.005","article-title":"Incidence of acute kidney injury in cancer patients: a Danish population-based cohort study","volume":"22","author":"Christiansen","year":"2011","journal-title":"Eur J Intern Med"},{"key":"10.1016\/j.nefroe.2025.501332_bib0160","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1093\/ckj\/sfab292","article-title":"Treatment of acute kidney injury in cancer patients","volume":"15","author":"Braet","year":"2022","journal-title":"Clin Kidney J"},{"key":"10.1016\/j.nefroe.2025.501332_bib0165","first-page":"77","article-title":"Nephrotoxicity in cancer treatment: an update","volume":"vol. 155","author":"Chen","year":"2022"},{"key":"10.1016\/j.nefroe.2025.501332_bib0170","doi-asserted-by":"crossref","first-page":"561","DOI":"10.3390\/cancers16030561","article-title":"Severe acute kidney injury in hospitalised cancer patients: epidemiology and predictive model of renal replacement therapy and in-hospital mortality","volume":"16","author":"Cal\u00e7as Marques","year":"2024","journal-title":"Cancers"},{"key":"10.1016\/j.nefroe.2025.501332_bib0175","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1681\/ASN.2004100843","article-title":"Renal failure associated with cancer and its treatment: an update","volume":"16","author":"Humphreys","year":"2005","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.nefroe.2025.501332_bib0180","doi-asserted-by":"crossref","first-page":"4618","DOI":"10.3390\/ijms22094618","article-title":"Nephrotoxicity as a complication of chemotherapy and immunotherapy in the treatment of colorectal cancer. Melanoma and non-small cell lung cancer","volume":"22","author":"Jagie\u0142a","year":"2021","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.nefroe.2025.501332_bib0185","doi-asserted-by":"crossref","first-page":"190","DOI":"10.5306\/wjco.v11.i4.190","article-title":"Nephrotoxicity in cancer treatment: an overview","volume":"11","author":"Santos","year":"2020","journal-title":"World J Clin Oncol"},{"key":"10.1016\/j.nefroe.2025.501332_bib0190","doi-asserted-by":"crossref","first-page":"2490","DOI":"10.3390\/toxins2112490","article-title":"Mechanisms of cisplatin nephrotoxicity","volume":"2","author":"Miller","year":"2010","journal-title":"Toxins"},{"key":"10.1016\/j.nefroe.2025.501332_bib0195","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1056\/NEJMoa0707330","article-title":"VEGF inhibition and renal thrombotic microangiopathy","volume":"358","author":"Eremina","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.nefroe.2025.501332_bib0200","doi-asserted-by":"crossref","first-page":"927","DOI":"10.2215\/CJN.0000000000000395","article-title":"Pharmacology of tyrosine kinase inhibitors: implications for patients with kidney diseases","volume":"19","author":"Hulin","year":"2024","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.nefroe.2025.501332_bib0205","doi-asserted-by":"crossref","first-page":"1353339","DOI":"10.3389\/fimmu.2024.1353339","article-title":"Immune checkpoint inhibitors and acute kidney injury","volume":"15","author":"Zhou","year":"2024","journal-title":"Front Immunol"},{"key":"10.1016\/j.nefroe.2025.501332_bib0210","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1517\/14656566.4.6.889","article-title":"Toxicity of platinum compounds","volume":"4","author":"Hartmann","year":"2003","journal-title":"Expert Opin Pharmacother"},{"key":"10.1016\/j.nefroe.2025.501332_bib0215","doi-asserted-by":"crossref","first-page":"2006","DOI":"10.1093\/ndt\/gfv372","article-title":"Acute kidney injury in critically ill patients with haematological malignancies: results of a multicentre cohort study from the Groupe de Recherche en R\u00e9animation Respiratoire en Onco-H\u00e9matologie","volume":"30","author":"Darmon","year":"2015","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.nefroe.2025.501332_bib0220","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1093\/jnci\/djy167","article-title":"Acute kidney injury in patients receiving systemic treatment for cancer: a population-based cohort study","volume":"111","author":"Kitchlu","year":"2019","journal-title":"JNCI J Natl Cancer Inst"},{"key":"10.1016\/j.nefroe.2025.501332_bib0225","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1186\/s12885-023-11561-3","article-title":"Incidence and risk factors of acute kidney injury in patients with malignant tumors: a systematic review and meta-analysis","volume":"23","author":"Can","year":"2023","journal-title":"BMC Cancer"},{"key":"10.1016\/j.nefroe.2025.501332_bib0230","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1093\/ckj\/sfac194","article-title":"The association between acute kidney injury and outcomes in cancer patients receiving immune checkpoint inhibitor therapy: a systematic review and meta-analysis","volume":"16","author":"Kanbay","year":"2023","journal-title":"Clin Kidney J"},{"key":"10.1016\/j.nefroe.2025.501332_bib0235","doi-asserted-by":"crossref","first-page":"2039","DOI":"10.1681\/ASN.2018050488","article-title":"Nephrotoxicity of cancer immunotherapies: past, present and future","volume":"29","author":"Perazella","year":"2018","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.nefroe.2025.501332_bib0240","first-page":"154","article-title":"Monographic consultation of onconephrology. Rationale and implementation","volume":"41","author":"Alonso","year":"2021","journal-title":"Nefrol Engl Ed"},{"key":"10.1016\/j.nefroe.2025.501332_bib0245","doi-asserted-by":"crossref","first-page":"418","DOI":"10.2215\/CJN.03361006","article-title":"North east italian prospective hospital renal outcome survey on acute kidney injury (NEiPHROS-AKI): targeting the problem with the RIFLE criteria","volume":"2","author":"Cruz","year":"2007","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.nefroe.2025.501332_bib0250","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1007\/s00134-012-2796-5","article-title":"Incidence, risk factors and 90-day mortality of patients with acute kidney injury in Finnish intensive care units: the FINNAKI study","volume":"39","author":"Nisula","year":"2013","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.nefroe.2025.501332_bib0255","doi-asserted-by":"crossref","first-page":"1692","DOI":"10.1007\/s00134-009-1530-4","article-title":"Acute kidney injury in critically ill patients classified by AKIN versus RIFLE using the SAPS 3 database","volume":"35","author":"Joannidis","year":"2009","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.nefroe.2025.501332_bib0260","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1056\/NEJMoa0802639","article-title":"Intensity of renal support in critically ill patients with acute kidney injury","volume":"359","author":"Palevsky","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.nefroe.2025.501332_bib0265","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1056\/NEJMoa0902413","article-title":"Intensity of continuous renal-replacement therapy in critically ill patients","volume":"361","author":"Bellomo","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.nefroe.2025.501332_bib0270","doi-asserted-by":"crossref","first-page":"2740","DOI":"10.1002\/cam4.2140","article-title":"Acute kidney injury predicts all-cause mortality in patients with cancer","volume":"8","author":"Kang","year":"2019","journal-title":"Cancer Med"},{"key":"10.1016\/j.nefroe.2025.501332_bib0275","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1093\/ndt\/gfh637","article-title":"Outcome in critically ill medical patients treated with renal replacement therapy for acute renal failure: comparison between patients with and those without haematological malignancies","volume":"20","author":"Benoit","year":"2005","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.nefroe.2025.501332_bib0280","unstructured":"National Institute for Health and Care Excellence. Acute kidney injury: prevention, detection and management (NG148)."},{"key":"10.1016\/j.nefroe.2025.501332_bib0285","doi-asserted-by":"crossref","first-page":"559","DOI":"10.2174\/1389200218666171108154419","article-title":"Drug-induced nephrotoxicity: pathogenic mechanisms, biomarkers and prevention strategies","volume":"19","author":"Wu","year":"2018","journal-title":"Curr Drug Metab"},{"key":"10.1016\/j.nefroe.2025.501332_bib0290","series-title":"Contributions to nephrology","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1159\/000102085","article-title":"Emerging biomarkers of acute kidney injury","author":"Devarajan","year":"2007"}],"container-title":["Nefrolog\u00eda (English Edition)"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2013251425000860?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2013251425000860?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,5]],"date-time":"2025-09-05T21:08:28Z","timestamp":1757106508000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2013251425000860"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":29,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,6]]}},"alternative-id":["S2013251425000860"],"URL":"https:\/\/doi.org\/10.1016\/j.nefroe.2025.501332","relation":{},"ISSN":["2013-2514"],"issn-type":[{"type":"print","value":"2013-2514"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pharmacological nephrotoxicity profile in a comprehensive cancer center: What changed in two decades and predictors for the need for haemodialysis and mortality","name":"articletitle","label":"Article Title"},{"value":"Nefrolog\u00eda (English Edition)","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nefroe.2025.501332","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Sociedad Espa\u00f1ola de Nefrolog\u00eda. Published by Elsevier Espa\u00f1a, S.L.U.","name":"copyright","label":"Copyright"}],"article-number":"501332"}}